Robert J. Toth, Jr., Scientific Operating Partner

Robert J. Toth, Jr. is a seasoned executive and advisor with two decades of experience in the biotech space. As Scientific Operating Partner at Bonaventure Equity, Mr. Toth will help build long term value in the innovative life science companies in which BVE invests.

Mr. Toth currently serves on the board of directors for Kintara Pharmaceuticals, Inc (2013-present), a NASDAQ-listed biotechnology company, and is also a Limited Partner at Northern Waters, LLC (2005-present). His previous roles include Consulting Analyst for Narragansett Asset Management (2004-2005), Senior Portfolio Manager for EGM Capital’s Medical Technology hedge fund (2001-2003), Senior Vice President and Biotechnology Analyst for Prudential Securities (1999-2001), Senior Biotechnology Analyst for Vector Securities International (1996-1999), business development and research roles for Connectics Corporation (1993-1996), intellectual property assessment and technology out-licensing for University of Washington’s Office of Technology Transfer (1992-1993), and manufacturing, research and clinical roles for Genentech, Inc. (1987-1991). In 1999, he was named to the Wall Street Journal's All-Star List for stock picking.

Mr. Toth holds an MBA from the University of Washington and dual Bachelor of Science degrees in Biological Sciences and Biochemistry from California Polytechnic State University, San Luis Obispo.